Your browser doesn't support javascript.
Severe COVID-19 anxiety among adults in the UK: protocol for a cohort study and nested feasibility trial of modified cognitive-behavioural therapy for health anxiety.
Crawford, Mike J; Leeson, Verity C; McQuaid, Aisling; Samuel, Oluwaseun; King, Jacob D; Di Simplicio, Martina; Tyrer, Peter; Tyrer, Helen; Watt, Richard G; Barnicot, Kirsten.
  • Crawford MJ; Division of Psychiatry, Imperial College London, London, UK m.crawford@imperial.ac.uk.
  • Leeson VC; Division of Psychiatry, Imperial College London, London, UK.
  • McQuaid A; Division of Psychiatry, Imperial College London, London, UK.
  • Samuel O; Division of Psychiatry, Imperial College London, London, UK.
  • King JD; Division of Psychiatry, Imperial College London, London, UK.
  • Di Simplicio M; Division of Psychiatry, Imperial College London, London, UK.
  • Tyrer P; Division of Psychiatry, Imperial College London, London, UK.
  • Tyrer H; Division of Psychiatry, Imperial College London, London, UK.
  • Watt RG; Epidemiology and Public Health, University College London, London, UK.
  • Barnicot K; School of Health Sciences, City University of London, London, UK.
BMJ Open ; 12(9): e059321, 2022 Sep 07.
Article in English | MEDLINE | ID: covidwho-2042862
ABSTRACT

INTRODUCTION:

Some people are so anxious about COVID-19 that it impairs their functioning. However, little is known about the course of severe COVID-19 anxiety or what can be done to help people who experience it. METHODS AND

ANALYSIS:

Cohort study with a nested feasibility trial with follow-up at 3 and 6 months. We recruited 306 people who were aged 18 and over, lived in the UK and had severe COVID-19 anxiety (indicated by a score of 9 or more on the Coronavirus Anxiety Scale (CAS)). To take part in the nested feasibility trial, participants also had to have a score of 20 or more on the Short Health Anxiety Inventory. We excluded people from the trial if they had had COVID-19 within the previous 4 weeks, if they were currently self-isolating or if they were already receiving psychological treatment.We publicised the study nationally through adverts, social media and posts on message boards. We also recruited participants via clinicians working in primary and secondary care NHS services in London. All those in the active arm will be offered 5-10 sessions of remotely delivered modified cognitive-behavioural therapy for health anxiety (CBT-HA). We will examine the proportion of participants who remain above threshold on the CAS at 3 and 6 months and factors that influence levels of COVID-19 anxiety over 6 months using mixed effects logistic regression. The key feasibility metrics for the nested trial are the level of uptake of CBT-HA and the rate of follow-up. ETHICS AND DISSEMINATION Approved by Leicester Central Research Ethics Committee (reference 20/EM/0238). The results of the study will be published in peer-reviewed scientific journals. TRIAL REGISTRATION NUMBER ISRCTN14973494.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cognitive Behavioral Therapy / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Humans Country/Region as subject: Europa Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2021-059321

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Cognitive Behavioral Therapy / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Humans Country/Region as subject: Europa Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2021-059321